Cedar featured in the New York City Healthcare Venture Capital Report 2019
We are delighted and honored to announce that Cedar is featured among the Top 25 Funded NYC Health Companies in the 2019 Healthcare Venture Capital Report. This is the second annual report put out by NYC Health Business Leaders, providing in-depth analysis of the companies, investors and trends driving healthcare investment in New York.
Cedar was one of five healthcare companies selected in the patient engagement category. Among the top trends predicted for NYC healthcare in 2019? You guessed it: Patient engagement. According to the report, patient-focused tools that “help patients simplify the complexities of access, adherence, benefits and payments help them take back some control. NYC is home to companies in all categories – Cedar, Force Therapeutics, AbleTo, Cecilia Health and Wellthie to name a few. These services address real gaps for patients and families which will lead employers and plans to cover them, driving growth in this category.”
“New York is a hot bed for entrepreneurship – there’s an incredible energy here that I’ve grown to love. The city has so many resources that, when utilized correctly, can really help put you on a path towards success. We believe that the engineering talent in NYC is on par with (or perhaps even beginning to surpass) Silicon Valley.”
– Florian Otto, CEO & Co-founder, Cedar
#15 Funded NYC Company, 2019 Healthcare Venture Capital Report